Abstract
Nanobodies (Nbs or VHHs) have great therapeutic potential and have been studied as a treatment for numerous diseases. In addition to being more cost-effective to produce, these camelid-derived single-domain antibody fragments are small, stable, soluble in aqueous solutions, and have high specificity and affinity for the target antigen. Furthermore, VHHs exhibit low toxicity and immunogeni…